deltatrials
Terminated EARLY_PHASE1 INTERVENTIONAL NCT01413451

Amatuximab for High Mesothelin Cancers

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

Sponsor: National Cancer Institute (NCI)

Updated 25 times since 2017 Last updated: Dec 14, 2019 Started: Jul 12, 2011 Primary completion: Nov 15, 2013 Completion: Nov 15, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

A EARLY_PHASE1 clinical study on Carcinoma, Non-Small-Cell Lung and Carcinoma, Pancreatic Ductal, this trial is terminated or withdrawn. The trial is conducted by National Cancer Institute (NCI) and has accumulated 25 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

25 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated EARLY_PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated EARLY_PHASE1

  4. Jan 2020 — Jan 2021 [monthly]

    Terminated EARLY_PHASE1

  5. Dec 2019 — Jan 2020 [monthly]

    Terminated EARLY_PHASE1

Show 20 earlier versions
  1. Nov 2019 — Dec 2019 [monthly]

    Terminated EARLY_PHASE1

  2. Oct 2019 — Nov 2019 [monthly]

    Terminated EARLY_PHASE1

  3. Sep 2019 — Oct 2019 [monthly]

    Terminated EARLY_PHASE1

  4. Aug 2019 — Sep 2019 [monthly]

    Terminated EARLY_PHASE1

  5. Jul 2019 — Aug 2019 [monthly]

    Terminated EARLY_PHASE1

  6. Jun 2019 — Jul 2019 [monthly]

    Terminated EARLY_PHASE1

  7. May 2019 — Jun 2019 [monthly]

    Terminated EARLY_PHASE1

  8. Apr 2019 — May 2019 [monthly]

    Terminated EARLY_PHASE1

  9. Mar 2019 — Apr 2019 [monthly]

    Terminated EARLY_PHASE1

  10. Feb 2019 — Mar 2019 [monthly]

    Terminated EARLY_PHASE1

  11. Jan 2019 — Feb 2019 [monthly]

    Terminated EARLY_PHASE1

  12. Dec 2018 — Jan 2019 [monthly]

    Terminated EARLY_PHASE1

  13. Nov 2018 — Dec 2018 [monthly]

    Terminated EARLY_PHASE1

  14. Oct 2018 — Nov 2018 [monthly]

    Terminated EARLY_PHASE1

  15. Sep 2018 — Oct 2018 [monthly]

    Terminated EARLY_PHASE1

  16. Aug 2018 — Sep 2018 [monthly]

    Terminated EARLY_PHASE1

  17. Jul 2018 — Aug 2018 [monthly]

    Terminated EARLY_PHASE1

  18. Jun 2018 — Jul 2018 [monthly]

    Terminated EARLY_PHASE1

  19. Feb 2017 — Jun 2018 [monthly]

    Terminated EARLY_PHASE1

    Phase: Phase 0EARLY_PHASE1

  20. Jan 2017 — Feb 2017 [monthly]

    Terminated Phase 0

    First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations